CAMBRIDGE, Mass. & OSAKA, Japan--(BUSINESS WIRE)--Takeda Pharmaceutical Company Limited (TSE: 4502/NYSE:TAK) (“Takeda”), today presented four abstracts at the Thrombosis and Hemostasis Summit of North ...
We invite you to attend this symposium featuring leading Hemostasis experts—Dr. Steven Pipe and Professor Katrien Devreese, along with two patient advocates. Tracye Hamler, diagnosed with hemophilia B ...
The glycoprotein V of the blood platelets is an important switch point for hemostasis and thrombus formation. This new finding could have great clinical potential. When our blood vessels are injured ...
A new research perspective titled "Preclinical and clinical evaluation of the Janus Kinase inhibitor ruxolitinib in multiple myeloma" has been published in Oncotarget. Cedars-Sinai Cancer ...
High-molecular-weight hydroxyethyl starches (hetastarches) can cause acquired type I von Willebrand's disease. 1 A case has also occurred after treatment with medium-molecular-weight hydroxyethyl ...
Researchers at the Indiana University Melvin and Bren Simon Comprehensive Cancer Center have uncovered biological differences in how multiple myeloma develops and progresses in men and in women. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results